...In an opposition brought by Nabi, Cytos, Novartis and Independent Pharmaceutica, the European Patent Office (EPO) revoked...
...plans. Nabi's NicVax nicotine conjugate vaccine is in Phase III testing to prevent nicotine dependence. Independent Pharmaceutica's...
...to treat nicotine addiction (see BioCentury, June 27, 2005). Cytos Biotechnology AG (SIX:CYTN), Zurich, Switzerland Independent Pharmaceutica AB...

...company began a 1-year, double-blind, placebo-controlled, Scandinavian Phase II trial of Niccine in 400 patients. Independent Pharmaceutica AB...